All News
Filter News
Found 73,951 articles
-
Daré Bioscience and Avomeen Form Strategic Partnership to Accelerate the Development of Daré’s Novel Pipeline of Women’s Health Programs
9/1/2020
Daré Bioscience, Inc. announced that the companies have signed an agreement under which Avomeen will provide contract product development laboratory services with a team specifically assembled to support the advancement of Daré’s innovative pipeline of investigational products designed to address persistent unmet needs in women’s health.
-
Selecta Biosciences Secures Up To $35 Million Debt Financing with Oxford Finance LLC and Silicon Valley Bank
9/1/2020
Selecta Biosciences, Inc. (NASDAQ: SELB), a clinical-stage biotechnology company focused on unlocking the full potential of biologic therapies based on its immune tolerance platform, ImmTORTM, today announced that it has entered into a debt financing facility for up to $35 million with Oxford Finance and Silicon Valley Bank (SVB).
-
HDT BIO Receives NIH Contract to Advance Novel RNA/LION™ COVID-19 Vaccine Into Clinical Trials
9/1/2020
HDT Bio Corp. recently received a notice of award from the National Institute of Allergy and Infectious Disease at the National Institutes of Health.
-
MediciNova Announces Development Progress on Intranasal Formulation of SARS-CoV-2 Vaccine for COVID-19New information for Spike protein specific antibody response after a single intranasal dose
9/1/2020
MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ:MNOV) and the JASDAQ Market of the Tokyo Stock Exchange (Code Number: 4875), today announced development progress on its intranasal SARS-CoV-2 vaccine for COVID-19 utilizing BC-PIV, a viral vector platform technology developed by Mie University and BioComo. We have designed multiple vaccine prototypes using a number of combinations of modality and anti
-
10,000th Patient Receives Treatment with ViewRay's MRIdian System
9/1/2020
ViewRay, Inc. (Nasdaq: VRAY) announced today that 10,000 patients have been treated to date using the company's MRIdian ® MRI-Guided Radiation Therapy System, the world's first system to combine MR imaging with r
-
Annovis Bio Begins Treatment of First Patients in its Phase 2a Alzheimer’s and Parkinson’s Trial
9/1/2020
Annovis Bio Inc. (NYSE American: ANVS), a clinical-stage drug platform company addressing Alzheimer’s disease (AD), Parkinson’s disease (PD) and other neurodegenerative diseases, today announced dosing of the first three patients in its new Phase 2a clinical trial targeting early AD and PD patients. The two-part study, which received IRB approval in July 2020, is designed to treat a combined total of 28 AD and PD patients for four weeks with An
-
Aptorum Group Limited Reports Financial Results and Business Update for the Six Months Ended June 30, 2020
9/1/2020
Aptorum Group Limited, a biopharmaceutical company focuses on the development of novel therapeutics to address global unmet medical needs, provided a business update and announced financial results for the six months ended June 30, 2020.
-
Kelyniam Global Releases 2nd Quarter 2020 Financials
9/1/2020
Kelyniam Global, a maker of custom cranial implants, announced results for its half year ended June 30, 2020.
-
Emergex Vaccines Forms US Subsidiary (Emergex USA) by Acquisition of Laboratories, Technology and Assets of US-Based T Cell Specialist Biotech ImmProNano
9/1/2020
Acquisition brings critical technical pre-clinical vaccine development capabilities in-house and establishes US based Emergex subsidiary
-
GAAPP and AstraZeneca launch campaign to help asthma patients break over-reliance on their SABA 'blue' reliever inhaler to prevent asthma attacks
9/1/2020
People with asthma encouraged to take new Reliever Reliance Test that assesses levels of reliance on their SABA 'blue' inhaler and supports relevant consultations with health professionals
-
Sparta Secures Distribution & Development Agreement with Encompass Power Solutions
9/1/2020
Sparta Group has entered into an agreement with Encompass Power Solutions Corp to distribute the entire line of Encompass products and services, as well as develop correlative technology.
-
BerGenBio to Present at Upcoming Investor Conferences - Sep 01, 2020
9/1/2020
BerGenBio ASA, a clinical-stage biopharmaceutical company developing novel, selective AXL kinase inhibitors for severe unmet medical need, is pleased to announce that a member of the senior management team will be presenting at the following virtual conferences:
-
Blood Cancer Patients Need Support Now More Than Ever
9/1/2020
Global leader in fighting blood cancer, The Leukemia & Lymphoma Society, remains laser-focused on its mission amidst pandemic
-
MDA Advocacy Institute - Facebook Live - Q&A: Accessible Voting in the 2020 Election for People with Disabilities -- Featuring U.S. Senator Bob Casey, Hosted by MDA's Kristin Stephenson, Friday, September 11 at 2:30pm ET
9/1/2020
What: The Muscular Dystrophy Association's Advocacy Institute invites you to join a special virtual conversation on Facebook Live featuring U.S.
-
IBM Watson Health and OrbitalRX to Launch Integrated Solution to Assist Hospital Pharmacy Providers in Managing Drug Shortages
9/1/2020
Joint offering pairs pharmacy supply chain management capabilities with evidence-based drug content, designed to help hospital pharmacy teams manage drug shortages
-
Lincotek Medical's Path to Resilient Infrastructure
9/1/2020
The Company Has Taken the Next Step in Its Global Medical Coatings Investment Program by Increasing Its Coating Capacity for Orthopedic Implants and Strengthening Its Global Risk Mitigation Capabilities, Adding Two Additional APS Lines in Its Trento Facility
-
Combinati Offers Unique Whole Product Digital PCR Testing Solution For COVID-19 Research
9/1/2020
Combinati Absolute Q® and Combinati |Q| SARS-CoV-2 Triplex Assay Provide Researchers with More Accurate, Precise and Sensitive Virus Detection
-
PMI® at 56.0%; August 2020 Manufacturing ISM® Report On Business®
9/1/2020
New Orders and Production Growing; Employment Contracting; Supplier Deliveries Slowing at Faster Rate; Backlog Growing; Raw Materials Inventories Contracting; Customers' Inventories Too Low; Prices Increasing; Exports and Imports Growing
-
Exact Sciences to participate in September investor conference - Sep 01, 2020
9/1/2020
Exact Sciences Corp. announced that company management will participate in the following conference and invited investors to participate by webcast.
-
Relation Therapeutics Teams up With Mila in Coalition to Identify COVID-19 Therapeutic Candidates
9/1/2020
Relation Therapeutics, a drug development company driven by data science and machine learning, announces Project RE, which will apply Relation Therapeutics’ and its partners’ technology to the identification of repurposed drug combinations as potential therapeutic candidates for COVID-19.